Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 213Myelodysplastic Syndromes 82Leukemia 44Leukemia, Myelomonocytic, Chronic 35Recurrence 16Myeloproliferative Disorders 15Neoplasm, Residual 10Lymphoma, T-Cell, Peripheral 10Leukemia, Biphenotypic, Acute 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7Myelodysplastic-Myeloproliferative Diseases 7Lymphoma, Large B-Cell, Diffuse 7Anemia, Refractory, with Excess of Blasts 7Primary Myelofibrosis 6Lymphoma, Non-Hodgkin 6Hodgkin Disease 6Congenital Abnormalities 6Lymphoma, T-Cell 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Leukemia, Monocytic, Acute 5Leukemia, Lymphocytic, Chronic, B-Cell 5Hematologic Neoplasms 5Polycythemia Vera 4Pancreatic Neoplasms 4Multiple Myeloma 4Lymphoma, Follicular 4Lymphoma, Extranodal NK-T-Cell 4Leukemia, Myeloid 4

Interventions

sintilimab 2pembrolizumab 2Nivolumab 2Immune Checkpoint Inhibitors 2Bevacizumab 2relatlimab 1epacadostat 1dabrafenib 1copanlisib 1atezolizumab 1Tiragolumab 1Oxaliplatin 1Cetuximab 1Capecitabine 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Spinocerebellar Degenerations × Azacitidine × Clear all
NCT03182894 2018-08-28

Epacadostat in Combination With Pembrolizumab and Azacitidine in Subjects With Metastatic Colorectal Cancer

University of Pittsburgh

Phase 1/2 Withdrawn
Gastrointestinal

Spinocerebellar Degenerations, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡